<?php
/**
 * MinMaxMuscle Forum - Pending Thread Creation Script
 * Compound: Retatrutide (LY3437943)
 * Generated: 2026-11-08
 *
 * NOTE: SSH access not available from cloud agent session.
 * To create the forum thread, run this script on the WordPress server
 * or paste the thread content into the Asgaros Forum admin panel.
 *
 * Usage (server-side):
 *   php forum_pending/20261108_retatrutide.php
 *
 * Or via WP-CLI:
 *   wp eval-file forum_pending/20261108_retatrutide.php
 */

// Requires WordPress environment. If running via wp eval-file, WP is already loaded.
// Otherwise, define WP_USE_THEMES and load wp-load.php before using these functions.

$thread_title = 'New Research Thread: Retatrutide (LY3437943) — Triple Agonist Beats Ozempic 2:1 Head-to-Head, 6 Phase 3 Wins';

$thread_content = '<p><strong>Retatrutide (LY3437943)</strong> is Eli Lilly\'s GLP-1/GIP/glucagon triple agonist and arguably the most significant new obesity drug in development. Here\'s the full research picture as of November 2026.</p>

<h4>Why retatrutide matters right now</h4>
<p>TRANSCEND-T2D-2 (October 28, 2026): First prospective head-to-head trial vs. Ozempic 2 mg. Retatrutide 12 mg delivered <strong>-20.9% weight (-47.4 lbs)</strong> vs. <strong>-9.4% (-20.9 lbs)</strong> for Ozempic — more than double. This was the 6th positive Phase 3 trial for the compound.</p>

<h4>TRIUMPH Program Summary</h4>
<ul>
<li><strong>TRIUMPH-1 (obesity)</strong>: Up to 28.3% weight loss at 80 weeks. 45.3% of participants lost ≥30% body weight — surgical-range results from a weekly injection.</li>
<li><strong>TRIUMPH-2 (T2D + obesity)</strong>: 20.8% weight loss</li>
<li><strong>TRIUMPH-3 (severe obesity + CVD)</strong>: 22.6% weight loss</li>
<li><strong>TRIUMPH OA</strong>: Positive for knee osteoarthritis pain</li>
<li><strong>TRIUMPH OSA</strong>: Positive for sleep apnea severity</li>
<li><strong>TRANSCEND-T2D-2</strong>: Beats Ozempic 2 mg in direct comparison</li>
</ul>

<h4>Mechanism: Why three receptors?</h4>
<p>GLP-1R reduces intake and slows gastric emptying. GIPR augments incretin effects (tirzepatide\'s advantage). Glucagon receptor drives direct hepatic fat oxidation and thermogenesis — the third layer that separates retatrutide from both semaglutide and tirzepatide. The additive result is more weight loss than either mono or dual agonism achieves.</p>

<h4>What\'s next</h4>
<p>Lilly plans FDA BLA filing in Q1 2027. TRIUMPH-5 (head-to-head vs. tirzepatide) results expected late 2026 / early 2027. That\'s the trial everyone is watching.</p>

<p>Full research dossier: <a href="https://minmaxmuscle.com/peptides/retatrutide">minmaxmuscle.com/peptides/retatrutide</a></p>
<p>Blog post: <a href="https://blog.minmaxmuscle.com/retatrutide-ly3437943-triple-agonist-obesity-phase3-research-dossier/">Research Dossier →</a></p>

<p><em>Discussion questions: Who\'s following the TRIUMPH-5 results? What do you think the ceiling is for triple agonism? And does the glucagon component create meaningful thermogenic effects in real-world use?</em></p>';

// Try Asgaros Forum REST endpoint first, fall back to standard WP post
$asgaros_endpoint = get_rest_url(null, 'asgaros-forum/v1/topics');
$post_args = array(
    'title'   => $thread_title,
    'content' => $thread_content,
    'status'  => 'publish',
);

// Check if Asgaros REST API is available
$routes = rest_get_server()->get_routes();
if (isset($routes['/asgaros-forum/v1/topics'])) {
    // Use Asgaros endpoint
    $request = new WP_REST_Request('POST', '/asgaros-forum/v1/topics');
    $request->set_param('title', $thread_title);
    $request->set_param('content', $thread_content);
    $request->set_param('status', 'publish');
    $response = rest_do_request($request);
    echo "Forum thread creation via Asgaros REST: " . ($response->get_status() == 200 ? "SUCCESS" : "Status " . $response->get_status()) . "\n";
} else {
    // Fall back to standard WP post
    $post_id = wp_insert_post(array(
        'post_title'   => $thread_title,
        'post_content' => $thread_content,
        'post_status'  => 'publish',
        'post_type'    => 'post',
        'post_author'  => 1,
    ), true);

    if (is_wp_error($post_id)) {
        echo "Forum fallback post error: " . $post_id->get_error_message() . "\n";
    } else {
        echo "Forum fallback post created with ID: $post_id\n";
        echo "URL: " . get_permalink($post_id) . "\n";
    }
}
